CADTH & Advisory Panel for a Pan-Canadian Prescription Drug List –
CADTH was chosen to establish the Advisory Panel to develop a framework for a pan-Canadian prescription drug list. CADTH will provide this service to Health Canada due to its relationship with federal, provincial, and territorial jurisdictions and other healthcare stakeholders on top of its experience in:
- the management of pharmaceuticals
- pan-Canadian expert panel
The Advisory Panel members include a diverse range of experienced experts from across Canada to provide recommendations by the end of April 2022.